CLDX
Celldex Therapeutics, Inc. · NASDAQ
- Sector Health Services
- Industry Medical/Nursing Services
- Website celldex.com
- Employees(FY) 148
- ISIN US15117B2025
Performance
-6.94%
1W
-1.01%
1M
-0.1%
3M
+37.5%
6M
-3.66%
YTD
+18.74%
1Y
Profile
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity; CDX-1140, a human agonist monoclonal antibody targeted to CD40, a key activator of immune response, which is found on dendritic cells, macrophages, and B cells, as well as is expressed on various cancer cells; and CDX-527, a bispecific antibody, which uses the company's proprietary active anti-PD-L1 and CD27 human antibodies to couple CD27 costimulation with blockade of the PD-L1/PD-1 pathway to help prime and activate anti-tumor T cell responses through CD27 costimulation. It has research collaboration and license agreements with University of Southampton to develop human antibodies towards CD27; Amgen Inc. with exclusive rights to CDX-301 and CD40 ligand; and Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
Investment Analysis Report: CLDX
Overview
In this investment analysis report, we will delve into the financial statements of CLDX, a company operating in the Health Services sector within the Medical/Nursing Services industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ...
Technical Analysis of CLDX 2024-05-10
Overview:
In analyzing the technical indicators for CLDX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been trending above the Simpl...
Recent News & Updates
- 2024-05-15 11:33
- 2024-05-15 08:01
- 2024-05-14 20:01
- 2024-05-09 09:55
- 2024-05-08 21:55
- 2024-05-08 06:51
- 2024-05-06 16:22
Celldex: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-06 16:01
- 2024-05-06 09:55
- 2024-05-06 04:01
- 2024-04-17 08:01
- 2024-04-16 20:01
- 2024-04-09 09:35
- 2024-04-08 21:35
- 2024-04-08 12:00
- 2024-04-08 09:35
- 2024-04-08 00:00
- 2024-04-07 21:35
- 2024-03-20 09:55
- 2024-03-19 21:55
- 2024-03-08 07:00
- 2024-03-07 18:00
- 2024-03-05 10:30
- 2024-03-05 10:10
- 2024-03-04 21:30
- 2024-03-04 21:10
- 2024-02-29 21:14
- 2024-02-29 12:00
- 2024-02-29 09:55
- 2024-02-29 08:14
Page 1 of 6
previousnext